Experiment: 2LNS

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-13C; U-15N; U-2H] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
2	2D 1H-13C HSQC	1 mM [U-15N; Iled1-[13CH3]; Leu,Val-[13CH3]] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
3	3D HN(COCA)CB	1 mM [U-13C; U-15N; U-2H] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
4	3D HNCO	1 mM [U-13C; U-15N; U-2H] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
5	3D HNCA	1 mM [U-13C; U-15N; U-2H] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
6	3D HNCACB	1 mM [U-13C; U-15N; U-2H] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
7	3D HN(CO)CA	1 mM [U-13C; U-15N; U-2H] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
8	2D 1H-15N HSQC	1 mM [U-15N; Iled1-[13CH3]; Leu,Val-[13CH3]] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
9	3D 1H-15N NOESY	1 mM [U-15N; Iled1-[13CH3]; Leu,Val-[13CH3]] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
10	3D 1H-13C NOESY	1 mM [U-15N; Iled1-[13CH3]; Leu,Val-[13CH3]] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298
11	IPAP	1 mM [U-15N] AGR2, 10 mg Pf1 phage	90% H2O/10% D2O	0.1	6.5	ambient	298
12	IPAP	1 mM [U-15N] AGR2, 5 % PEG:Hexanol	PEG	0.1	6.5	ambient	298
13	3D HN(CA)CO	1 mM [U-13C; U-15N; U-2H] AGR2	90% H2O/10% D2O	0.1	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing		CNSSOLVE

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	300
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CNSSOLVE		Brunger, Adams, Clore, Gros, Nilges and Read
2	refinement	CNSSOLVE		Brunger, Adams, Clore, Gros, Nilges and Read
3	peak picking	Analysis		CCPN
4	chemical shift assignment	Analysis		CCPN
5	collection	TopSpin		Bruker Biospin
6	processing	TopSpin		Bruker Biospin

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.